Atezolizumab,Paclitaxel,Bevacizumab
medsir,Roche
['tnbc', 'breast', 'medsir']
head over to the posters to discuss some of the results of our #atractib trial with which is evaluating treatment for triple negative breast cancer. #asco22 #breastcancer #tnbc 
Bring your idea to life?? 
Creating successful IITs & optimizing drug development ?? 
Medica Scientia Innovation Research
 ????&????
https://t.co/yp3O5Lylqc